Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder
Sage Therapeutics
PR-M06-21-023Jun 18, 2021
Clinical Results
VistaGen Reports Topline Phase 2 Results for AV-101 as an Adjunctive Treatment of Major Depressive Disorder
VistaGen Therapeutics
PR-M11-19-NI-019Nov 19, 2019
Drug Development
Looking Beyond Current Treatments for CNS Diseases and Disorders
Shawn Singh
VistaGen Therapeutics
PAP-Q3-19-CL-036Oct 28, 2019
Depression
Trump Urges VA to Use Spravato
Nice Insight
PAO-M00-19-NI-007Sep 04, 2019
Phase III
Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression
Nice Insight
PR-M07-19-NI-023Jul 10, 2019
Drug Development
NeuroRx Reports Phase 2 Efficacy for NRX-101, a Breakthrough Therapy Targeting Suicidal Bipolar Depression
NeuroRx
PR-M06-19-NI-004Jun 07, 2019
Opioid Treatment
Failed Depression Drug Could be Opioid Addiction Treatment
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-012Apr 10, 2019
Genetic Testing
Using Genetic Data to Fight Depression
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-19-NI-001Apr 02, 2019
FDA Approval
FDA Approves New Nasal Spray Medication for Treatment-resistant Depression; Available Only at a Certified Doctor's Office or Clinic
U.S. Food & Drug Administration
PR-M03-19-NI-027Mar 11, 2019
FDA
FDA Advisory Committee Recommends Approval of SPRAVATO™ (esketamine) Nasal Spray CIII for Adults with Treatment-Resistant Depression
Janssen Pharmaceutical Companies
PR-M02-19-NI-030Feb 14, 2019
Clinical Trials
Depression Drug Shows Early Positive Results
Emilie Branch
Pharma's Almanac
PAO-M01-19-NI-014Jan 25, 2019
Depression
New Data Presented at Psych Congress 2018 Sheds Light on the Significant Economic Burden of Treatment-Resistant Depression Amongst U.S. Veterans
Janssen Pharmaceutical Companies
PR-M10-18-NI-104Oct 30, 2018
Innovation
Shining a Light on Depression - How Infrared Light Can Treat Depression
The Neuro-Laser Foundation
PR-M10-18-NI-030Oct 09, 2018
Data Presentation
Janssen to Present Data in Treatment-Resistant Mental Ilnesses
Janssen Pharmaceutical Companies
PR-M05-18-NI-029May 08, 2018